Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 9 January 2025
First Online: 30 January 2025
Competing interests
: B.L.N. has received fees for travel support, advisory boards, scientific presentations and steering committee roles from AstraZeneca, Alexion, Bayer, Boehringer and Ingelheim, Janssen, Novo Nordisk and Travere Therapeutics. The other authors declare no competing interests.
